Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
NKGen Biotech, Inc.Listing on record | Buy | $2.6M | conv 76First in 12mo | SEC | |
NKGen Biotech, Inc.Listing on record | BuyD (derivative) | $5.1M | First in 12mo | SEC |